Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Manac is a Japanese specialty chemical company that operates as a Contract Development and Manufacturing Organization (CDMO) for the global pharmaceutical and life sciences industries. The company specializes in the synthesis of fine chemicals, with a core competency in bromine and iodine chemistry, including complex halogenation processes. Manac provides a range of services from process development to commercial-scale manufacturing of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) under GMP conditions. In addition to its healthcare business, the company develops flame retardants and high-performance materials for the electronics and automotive sectors. Manac is headquartered in Hiroshima and is a subsidiary of Manac Chemical Partners Co., Ltd., which is listed on the Tokyo Stock Exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Manac.